Ayatollahi Azin, Hosseini Hamed, Gholami Jaleh, Mirminachi Babak, Firooz FaridHossein, Firooz Alireza
a Center for Research and Training in Skin diseases and Leprosy, Tehran University of Medical Science , Tehran , Iran.
b Clinical Trial Center, Tehran University of Medical Science , Tehran , Iran.
J Dermatolog Treat. 2017 Nov;28(7):574-581. doi: 10.1080/09546634.2017.1303571. Epub 2017 Mar 23.
Although there are many studies showing the role of platelet rich plasma (PRP) in bone grafts, teeth osteosynthesis, and wound healing, there have been little peer reviewed studies about the safety and efficacy of PRP application in the treatment of hair loss.
In this systematic review, we searched Ovid Medline, Scopus and Web of Knowledge till November 2015 for human studies evaluating the efficacy of PRP for the treatment of non-cicatricial alopecia.
Among 704 articles retrieved in first search, 18 articles matched our inclusion criteria, 14 for androgenic alopecia and four for alopecia areata. They included two case reports, eight case series, six controlled clinical trials and only two randomized controlled trials.
Most of the available evidence has shown low quality and controversial results about the efficacy of PRP in treating non-cicatricial alopecias, including androgenetic alopecia and alopecia areata. Further randomized controlled studies with more sample size and standard protocols regarding the number and interval of treatment sessions, number of platelets, method of activation, etc., are required to investigate the efficacy and safety of PRP in treating hair loss.
尽管有许多研究表明富血小板血浆(PRP)在骨移植、牙齿骨合成和伤口愈合中的作用,但关于PRP应用于治疗脱发的安全性和有效性的同行评审研究却很少。
在本系统评价中,我们检索了截至2015年11月的Ovid Medline、Scopus和Web of Knowledge数据库,以查找评估PRP治疗非瘢痕性脱发疗效的人体研究。
在首次检索到的704篇文章中,18篇符合我们的纳入标准,其中14篇关于雄激素性脱发,4篇关于斑秃。这些研究包括2篇病例报告、8篇病例系列、6项对照临床试验,仅有2项随机对照试验。
现有大多数证据表明,PRP治疗包括雄激素性脱发和斑秃在内的非瘢痕性脱发的疗效质量较低且结果存在争议。需要进一步开展随机对照研究,扩大样本量并采用关于治疗疗程次数和间隔、血小板数量、激活方法等的标准方案,以研究PRP治疗脱发的有效性和安全性。